| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 206K | $3.36M | $16.33 | 09 Jan 2024 | Direct |
| Amylyx Pharmaceuticals, Inc. | Chief Medical Officer | Stock Option (right to buy) | 33.8K | 15 May 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 09 Jan 2024 | 1 | -$45.9K | 4 | Chief Medical Officer | 11 Jan 2024, 17:04 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 15 May 2023 | 5 | -$279K | 4 | Chief Medical Officer | 17 May 2023, 16:58 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 17 Apr 2023 | 6 | -$1.46M | 4 | Chief Medical Officer | 19 Apr 2023, 19:45 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 16 Mar 2023 | 10 | -$1.61M | 4/A | Chief Medical Officer | 24 Mar 2023, 18:45 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 06 Jan 2023 | 2 | $73.8K | 4 | Chief Medical Officer | 10 Jan 2023, 18:22 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 06 Jan 2022 | 2 | $0 | 4 | Chief Medical Officer | 10 Jan 2022, 19:34 |
| AMLX | Amylyx Pharmaceuticals, Inc. | 06 Jan 2022 | 0 | $0 | 3 | Chief Medical Officer | 06 Jan 2022, 16:02 |